Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Scripps Research Neuroscientists Find Brain Stem Cells that May Be Responsible for Higher Functions, Bigger Brains

  Scripps Research Neuroscientists Find Brain Stem Cells that May Be Responsible for Higher Functions, Bigger Brains August 10, 2012 (Scripps) - "Published in the August 10, 2012 issue of the journal Science, the new research reveals how neur ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

'Ghost Heart,' a Framework for Growing New Human Hearts, Could be Answer for Thousands Waiting for New Heart

  'Ghost Heart,' a Framework for Growing New Human Hearts, Could be Answer for Thousands Waiting for New Heart The problem: More than 3,200 people are on the waiting list for a heart transplant in the United States. Some won't survive the wait. La ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Stem Cell Injections After a Heart Attack Restore the Heart to a Healthy State

  Stem Cell Injections After a Heart Attack Restore the Heart to a Healthy State August 19, 2012 - (Cleveland.com) - "Early results show these patients end up with hearts that pump at nearly normal rates -- the way they did before the heart a ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

ReNeuron Receives DSMB Clearance to Progress to Higher Dose in Stem Cell Clinical Trial in Disabled Stroke Patients: First Patient Treated in this Higher Dose Cohort

  ReNeuron Receives DSMB Clearance to Progress to Higher Dose in Stem Cell Clinical Trial in Disabled Stroke Patients: First Patient Treated in this Higher Dose Cohort August 14, 2012 - (ReNeuron) - "ReNeuron provides an update on progress wi ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Pluristem Receives Approval from Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger's Disease

  Pluristem Receives Approval from Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger's Disease August 16, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc., a leading developer of placenta-based cell t ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Juventas Therapeutics doses first patient in Phase II STOP-HF trial

  Juventas Therapeutics doses first patient in Phase II STOP-HF trial August 20, 2012 - (The Sacramento Bee) - "Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovasc ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Autism and Cord Blood Stem Cells: FDA Gives Green Light for Groundbreaking Clinical Trial

  Autism and Cord Blood Stem Cells: FDA Gives Green Light for Groundbreaking Clinical Trial Aug. 21, 2012 - (Market Watch) - "Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells

  CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells  August 14, 2012 - (Cellular Dynamics) - "CeeTox and Cellular Dynamics International (CDI) today announced the intr ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Plasticell and EMD Millipore Complete Licensing Deal to Distribute Fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media

  Plasticell and EMD Millipore Complete Licensing Deal to Distribute Fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media August 14, 2012 - (Plasticell) - "Plasticell, the UK stem cell differentiation specialist has licensed E ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News

Stem Cell Tourism Hardly a Vacation

  Stem Cell Tourism Hardly a Vacation August 16, 2012 - (GEN) - "A July 23 federal court decision allows the agency to regulate as drugs clinical treatments produced from patients’ stem cells processed beyond “minimal” manipulation. The U.S. ...[Read More]
Published: Aug-23-12
Tags: Science and Industry News
 Next >>